DORI KING: Open Payments
NPI 1225525322 · GOLDSBORO, NC. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$188 in 10 payments from 6 companies in 2025. Trend: 2023 $154 · 2024 $402 · 2025 $188
Food & beverage: $188
| Company | Payments | Amount |
|---|---|---|
| Novo Nordisk Inc | 3 | $64 |
| Lilly USA, LLC | 2 | $39 |
| GlaxoSmithKline, LLC. | 2 | $31 |
| Abbott Laboratories | 1 | $20 |
| Merck Sharp & Dohme LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
Products named: Ozempic, ZEPBOUND, SHINGRIX, FREESTYLE LIBRE 3, Rybelsus, GARDASIL 9.
Industry payments across NC — which companies pay providers there.
